Guizhou Sanli Pharmaceutical Co.,Ltd (SHSE:603439) said it plans to acquire 50.26% stake in Pharma firm for CNY 499.6 million ($68.41 million). The company said it will own 75.9% stake in the Pharma firm after the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.25 CNY | +1.79% | -4.43% | -24.52% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.52% | 789M | |
+46.06% | 754B | |
+40.95% | 630B | |
-5.97% | 352B | |
+19.91% | 331B | |
+9.56% | 298B | |
+18.45% | 250B | |
+11.88% | 217B | |
-0.78% | 216B | |
+5.77% | 164B |
- Stock Market
- Equities
- 603439 Stock
- News GuiZhou SanLi Pharmaceutical Co.,Ltd
- Guizhou Sanli Pharma Plans Acquisition for CNY 499.6 Million